Woogene B&G Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Woogene B&G Co., Ltd. - overview
Established
1977
Location
Seoul, -, South Korea
Primary Industry
Biotechnology
About
Based in Seoul, South Korea, and founded in 1977, Woogene B&G Co. , Ltd. operates as a biotechnology company that manufactures and markets medicines for animals. In February 2021, it was awarded the Korea Veterinary Medicine Association President’s Award.
In April 2020, it signed a joint research and development agreement with Dr. I&B for companion animal cancer treatment. In October 2019, it acquired organic pet food manufacturing company OSP. The company developed the strains used to produce pharmaceuticals and feed additives which include swine, poultry, cattle, aquatic animal, and companion animal.
It also develops odor removers and environmental improvement agents.
Primary Industry
Biotechnology
Sub Industries
Pet Products, Biopharmaceuticals, Pharmaceutical Research & Development
Website
www.woogenebng.com
Total Amount Raised
Subscriber access only
Woogene B&G Co., Ltd. - timeline of key events
Woogene B&G Co., Ltd. - financials
| Fiscal Year Ended | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 21,267,393,108 | 20,545,996,532 | 22,086,598,893 | 23,506,552,575 | 24,235,437,425 | 22,933,552,769 | 28,130,628,894 | 29,655,799,738 | 39,524,380,436 | 39,347,387,678 | 43,703,465,297 | - | - | - |
| % Revenue Growth (YoY) | - | (3.4%) | 7.5% | 6.4% | 3.1% | (5.4%) | 22.7% | 5.4% | 33.3% | (0.4%) | 11.1% | - | - | - |
| EBITDA (USD) | 2,464,627,990 | 1,523,376,646 | 1,716,822,804 | 866,159,660 | 1,007,326,621 | (1,918,616,290) | (2,248,026,187) | 4,663,333,327 | 2,806,895,219 | 2,495,594,469 | 3,467,078,358 | - | - | - |
| Operating Income (USD) | 1,787,969,342 | 769,006,194 | 852,821,051 | (1,119,418) | 125,824,723 | (3,414,310,268) | (4,798,954,863) | 2,023,604,636 | 663,487,705 | 266,657,254 | 1,155,423,595 | - | - | - |
| Operating Margin | 8.4% | 3.7% | 3.9% | (0.0%) | 0.5% | (14.9%) | (17.1%) | 6.8% | 1.7% | 0.7% | 2.6% | - | - | - |
| % EBITDA Margin | 11.6% | 7.4% | 7.8% | 3.7% | 4.2% | (8.4%) | (8.0%) | 15.7% | 7.1% | 6.3% | 7.9% | - | - | - |
| NET Income (USD) | 1,275,859,203 | 606,352,505 | 821,343,127 | 352,764,170 | 175,430,222 | (4,190,242,470) | (6,632,215,498) | (13,551,503,700) | 865,340,963 | (1,038,911,104) | 1,012,603,381 | - | - | - |
| % Net Margin | 6.0% | 3.0% | 3.7% | 1.5% | 0.7% | (18.3%) | (23.6%) | (45.7%) | 2.2% | (2.6%) | 2.3% | - | - | - |
Woogene B&G Co., Ltd. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.